Laboratoires Iprad   Report issue

For profit Phase 3
Founded: Paris France (1976)
Status: No NME R&D (1976)

Organization Overview

First Clinical Trial
2010
NCT01733966
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now